| Added by | Cavailles |
|---|---|
| Group name | EquipeVC |
| Item Type | Journal Article |
| Title | Collaboration between cardiologist and clinical pharmacist on prescription quality: What is the potential clinical impact for cardiology patients? |
| Creator | Audurier et al. |
| Author | Yohan Audurier |
| Author | Nicolas Chapet |
| Author | Pierre Renaudin |
| Author | Carole Bons |
| Author | Betty Mathieu |
| Author | Sarah Theret |
| Author | Gaëlle de Barry |
| Author | Anne Jalabert |
| Author | Cyril Breuker |
| Author | Florence Leclercq |
| Author | Jean-Luc Pasquie |
| Author | Audrey Agullo |
| Author | François Roubille |
| Author | Audrey Castet-Nicolas |
| Abstract | OBJECTIVES: The aim of this study was to determine the effect of pharmacists' interventions (PI) on the potential clinical impact of medication errors, including the lack of therapeutic optimisation of patients with cardiologic diseases, such as heart failure and acute coronary syndrome). METHODS: This was an observational, prospective study conducted in the cardiology department of a French university hospital centre for a duration of 9 months. All prescriptions were analysed and PI were registered for clinical rating by pharmacists and cardiologist. RESULTS: A total of 532 PI cases were recorded in 339 patients, with a mean of 1.57 (±1.04) PI. The PI acceptance rate was 98.1%. "Dose adjustment" and "introduction therapy" were the most common interventions and represented 38.0% and 32.9%, respectively, of all PI. Statins were the most frequently involved drugs (18.1%), followed by ACE (Angiotensin Converting Enzyme) inhibitors (10.9%) and antiplatelet agents (9.3%). Moreover, 13.8% of PI potentially avoided a severe or very severe clinical impact (n = 71) and 38.6% had a significant impact altering the quality of life (n = 198). There was no significant difference between the average score performed by the clinical pharmacist included in the cardiology team and the one obtained by the cardiologist (P = .797). In contrast, a significant difference was observed for the average score established by the pharmacist localised in central pharmacy versus the rating of the cardiologist (P < .001). CONCLUSIONS: The collaboration between clinical pharmacists and cardiologists in the medical units seems to be beneficial to the quality of prescriptions, including the implementation of recommendations. The good rate of PI acceptance and the similar rating with the cardiologist show that there is a change in perspective of the pharmacist, being closer to the clinical reality. |
| Publication | International Journal of Clinical Practice |
| Volume | 74 |
| Issue | 9 |
| Pages | e13531 |
| Date | 2020-09 |
| Journal Abbr | Int J Clin Pract |
| Language | eng |
| DOI | 10.1111/ijcp.13531 |
| ISSN | 1742-1241 |
| Short Title | Collaboration between cardiologist and clinical pharmacist on prescription quality |
| Library Catalog | PubMed |
| Extra | PMID: 32459398 |
| Tags | Acute Coronary Syndrome, Adult, Angiotensin-Converting Enzyme Inhibitors, Cardiologists, Drug Prescriptions, Female, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, last, Male, Medication Errors, Middle Aged, Pharmacists, Pharmacy Service, Hospital, Prospective Studies |
| Date Added | 2021/09/01 - 17:15:21 |
| Date Modified | 2023/11/21 - 14:23:05 |
| Notes and Attachments | PubMed entry (Attachment) Version soumise (Attachment) |
Institut de Recherche en Cancérologie de
